RNA Therapeutics
- OliX Grants Hansoh Pharma Exclusive Rights to Two siRNA Sequences, With Room for More
OliX Pharmaceuticals has licensed development and commercialization rights to two siRNA sequences to China's Hansoh Pharma, with same-target follow-ons possible
